Compare Centrus Energy Corp (LEU) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Oscar Health Inc — how do they compare? Centrus Energy Corp trades at $142.44 (market cap $2.91B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 3.5× Centrus Energy Corp's market cap, and Oscar Health Inc is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 29 Days and Oscar Health Inc for 15 Days on average.
| LEU | OSCR | |
|---|---|---|
Market Cap | $2.91B | $10.22B |
Volume | 903,777 | 4,123,394 |
Sector | Energy | Health |
52-Week High | $436.00 | $33.81 |
52-Week Low | $138.18 | $10.85 |
Typical Hold Time | 29 Days | 15 Days |
Enterprise Value | $2.22B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $142.09, down 3.43% today, with a bearish technical signal from moving averages. The company reported mixed Q2 2026 earnings with an EPS beat but faces declining profitability margins year-over-year. Recent news highlights Centrus' strategic position as the sole US-licensed producer of high-assay low-enriched uranium (HALEU), securing multiple supply contracts amid growing nuclear energy demand.
Outlook: LEU offers exposure to the nuclear fuel supply chain with strong analyst support (46% buy ratings) and a $218.10 consensus price target. Key risks include execution challenges, volatile cash flows, and high valuation multiples (P/E 75.18). The stock's near-term performance hinges on operational execution and contract ramp-up.
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
